SPOT BIOSYSTEMS
Latest round
- Series A
Last raised
- Jun 2026
Total raised
- $40M
Investors
- 7
About SPOT BIOSYSTEMS
Spot Biosystems specializes in advancing gene delivery technologies, particularly targeting Duchenne muscular dystrophy. Founded in San Francisco, US, the company has strategically pivoted towards utilizing extracellular vesicles in its operations.Spot Biosystems specializes in a pioneering gene delivery platform utilizing extracellular vesicles (EVs) to enhance the safety and efficacy of gene therapies. This innovative technology targets various diseases with a primary focus on Duchenne muscular dystrophy, a severe genetic disorder. By enabling targeted and efficient delivery, Spot Biosystems aims to improve treatment outcomes for patients affected by genetic disorders.Spot Biosystems generates revenue through strategic partnerships and collaborations with pharmaceutical companies and research institutions interested in gene therapy applications. The company’s business model includes project-based agreements and licensing fees for its EV-mediated delivery technology, with transactions typically involving upfront payments and milestone payments as development stages are achieved. The company plans to expand its market presence into new geographic regions, including additional areas in Europe and Asia, by late 2026. This strategic growth will involve launching new products and enhancing collaborations within the biotechnology sector.
Who invested in SPOT BIOSYSTEMS
7 investors across 1 round
See all investors in SPOT BIOSYSTEMS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 17, 2026
Amount
$40M
Investors
Questions about SPOT BIOSYSTEMS
Who invested in SPOT BIOSYSTEMS?
SPOT BIOSYSTEMS has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SPOT BIOSYSTEMS raised?
SPOT BIOSYSTEMS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SPOT BIOSYSTEMS last raise money?
SPOT BIOSYSTEMS's most recent round on record is a Series A, in Jun 2026.
What does SPOT BIOSYSTEMS do?
Spot Biosystems specializes in advancing gene delivery technologies, particularly targeting Duchenne muscular dystrophy.
Where is SPOT BIOSYSTEMS headquartered?
SPOT BIOSYSTEMS is headquartered in San Francisco, US.
Which VCs invest in companies like SPOT BIOSYSTEMS?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at SPOT BIOSYSTEMS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SPOT BIOSYSTEMS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.